Subsidiaries
(€K)  Share capital  Shareholders’
equity other
than share
capital  Share held
(%) Gross
carrying
value of the
securities
held  Loans and
advances
granted by
the Parent
Company, not
yet repaid  Current
account with
the parent
company  Revenue
excl uding
taxes for the
past year  2019
Net Profit &
Loss
Nanobiotix
Corp.  3,001  (4,199)  100%  3,001  2,252  151  - 56
Nanobiotix
S.L.U.  3 (164)  100%  3 - 189  - 5
Nanobiotix
GmbH  25 (1) 100%  25 - (39)  - 13
Curadigm
SAS  1,023  (531)  100%  1,023  - 478  64 (1,044)


 2020_Nanobiotix_Universal Registration Document
Chapter 5. COMPANY AND CAPITAL INFORMATION

347
 4.4. STATUTORY AUDITOR'S REPORT ON THE 2020 COMPANY’S ANNUAL FINANCIAL
STATEMENTS
GRANT THORNTON
French member of Grant Thornton
International  ERNST & YOUNG et Autres

This is a translation into English of the statutory auditors’ report on the financial stat ements of the
Company issued in French and it is provided solely for the convenience of English -speaking users.
This statutory auditors’ report includes information required by European regulation and French law, such
as information about the  appointment o f the statutory auditors or verification of the management report
and other documents provided to the shareholders.
This report should be read in conjunction with, and construed in accordance with, French law and
professional auditing standar ds applicable in France.

### Language ###
English

### Assessment ###
We could ask about the financial relationship between Curadigm SAS and its parent company, specifically about the current account balance.

### Query ###
Tell me the current account balance between Curadigm SAS and its parent company.
Tell me the current account balance between Curadigm SAS and its parent company.